[[(2R,3S,4R,5R)-3,4-dihydroxy-5-[4-[3-(4-methoxyphenyl)propoxyamino]-2-oxopyrimidin-1-yl]oxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate

ID: ALA3261369

Max Phase: Preclinical

Molecular Formula: C19H28N3O16P3

Molecular Weight: 647.36

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1ccc(CCCO/N=c2/ccn([C@@H]3O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)[C@@H](O)[C@H]3O)c(=O)[nH]2)cc1

Standard InChI:  InChI=1S/C19H28N3O16P3/c1-33-13-6-4-12(5-7-13)3-2-10-34-21-15-8-9-22(19(25)20-15)18-17(24)16(23)14(36-18)11-35-40(29,30)38-41(31,32)37-39(26,27)28/h4-9,14,16-18,23-24H,2-3,10-11H2,1H3,(H,29,30)(H,31,32)(H,20,21,25)(H2,26,27,28)/t14-,16-,17-,18-/m1/s1

Standard InChI Key:  NIHFTZIOZPMEPG-VDHUWJSZSA-N

Associated Targets(Human)

P2RY2 Tclin Purinergic receptor P2Y2 (1109 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
P2RY4 Tchem Pyrimidinergic receptor P2Y4 (598 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
P2RY6 Tchem Pyrimidinergic receptor P2Y6 (717 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 647.36Molecular Weight (Monoisotopic): 647.0682AlogP: -0.39#Rotatable Bonds: 14
Polar Surface Area: 278.12Molecular Species: ACIDHBA: 14HBD: 7
#RO5 Violations: 3HBA (Lipinski): 19HBD (Lipinski): 7#RO5 Violations (Lipinski): 3
CX Acidic pKa: 0.90CX Basic pKa: CX LogP: -0.33CX LogD: -7.78
Aromatic Rings: 2Heavy Atoms: 41QED Weighted: 0.08Np Likeness Score: 0.93

References

1. Jayasekara PS, Barrett MO, Ball CB, Brown KA, Hammes E, Balasubramanian R, Harden TK, Jacobson KA..  (2014)  4-Alkyloxyimino derivatives of uridine-5'-triphosphate: distal modification of potent agonists as a strategy for molecular probes of P2Y2, P2Y4, and P2Y6 receptors.,  57  (9): [PMID:24712832] [10.1021/jm500367e]
2. Xu P, Feng X, Luan H, Wang J, Ge R, Li Z, Bian J..  (2018)  Current knowledge on the nucleotide agonists for the P2Y2 receptor.,  26  (2): [PMID:29254895] [10.1016/j.bmc.2017.11.043]

Source